NAD+ injections: real metabolic tool or overhyped wellness shot?
Quick answer
NAD+ is a coenzyme involved in mitochondrial electron transport and ATP synthesis, and plasma NAD+ levels do decline with age. The creator promotes IV NAD+ as superior to oral supplementation, but peer-reviewed evidence from 2020 to 2023 shows that oral NAD+ precursors such as NMN and NR raise intracellular NAD+ levels in human subjects, making the oral absorption claim more nuanced than presented. IV NAD+ infusions carry documented side effects during administration and lack robust human RCT data supporting the cognitive, athletic, and anti-aging outcomes the video lists.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @court.nurse actually say?
A nurse practitioner on TikTok made three core claims about NAD: that it acts as a "universal cellular electron transporter" that produces ATP, that oral NAD supplements are poorly absorbed and don't reach cells, and that NAD injections offer benefits including energy, cognitive function, athletic recovery, and anti-aging effects. The video is clearly promotional in tone, hashtagged with NAD injections and IV infusion content.
The creator stops short of citing any specific studies or dosing protocols, which keeps things vague enough to avoid obvious red flags. But vague isn't the same as accurate, and a few of these claims deserve a closer look before you book an infusion appointment.
Does the science back this up?
Partially, yes. NAD+ (nicotinamide adenine dinucleotide) does play a documented role in cellular energy metabolism, and the electron transport chain claim is broadly grounded in biochemistry. The oral bioavailability question is more complicated than the video suggests, and the anti-aging claim is being stretched well beyond what current human data supports.
On the energy side, NAD+ is a well-established coenzyme in mitochondrial function. A 2018 review by Rajman et al. in Cell Metabolism confirmed NAD+'s role in ATP synthesis and noted that NAD+ levels decline with age in multiple tissues. That part checks out. The IV delivery question is trickier. A 2023 study by Pencina et al. in the New England Journal of Medicine looked at NMN supplementation (an NAD+ precursor) orally and found it did raise NAD+ levels in muscle tissue in older men, which directly complicates the "pills don't work" narrative the creator pushes.
What did they get wrong (or right)?
The claim that oral NAD supplements are "not absorbed by the digestive system and not taken up directly by the cells" is the most problematic statement in the video. It is overstated and not well-supported by current literature.
NAD+ itself is not efficiently absorbed orally as a free molecule, that part is fair. But NAD+ precursors like NMN and NR (nicotinamide riboside) are absorbed and do raise intracellular NAD+ levels. The Pencina et al. 2023 NEJM study showed measurable muscle NAD+ increases with oral NMN. A 2020 clinical trial by Martens et al. in Nature Communications found that oral NR raised blood NAD+ metabolites in healthy middle-aged adults. Lumping all oral forms together as useless is a sales pitch, not a science briefing.
Credit where it's due: the electron transporter description, while simplified, is not wrong. NAD+ cycling between its oxidized and reduced forms (NADH) is central to how cells generate energy. That core biochemistry is accurate.
What should you actually know?
IV NAD+ infusions are being used clinically and in wellness settings, but the human trial evidence for most of the benefits listed in this video is still thin. "Cognitive function," "athletic performance," and "anti-aging" are marketing categories, not FDA-approved indications. No large randomized controlled trials in humans have confirmed that IV NAD+ infusions produce superior outcomes to well-studied oral precursors for healthy adults.
There are also safety considerations the video skips entirely. IV NAD+ infusions are known to cause uncomfortable side effects during administration, including chest tightness, nausea, and flushing, which are common enough to be documented in clinical protocols. The infusions are not without risk, and "nurse practitioner does it" is not a substitute for a formal risk-benefit conversation with a provider who knows your health history.
If you're genuinely interested in NAD+ optimization, the oral precursor literature is growing and more accessible than IV therapy. Talk to a licensed clinician who will actually review your labs, not just sell you a drip.
What's the bottom line on this video?
This video mixes solid basic biochemistry with an oversimplified dismissal of oral NAD precursors that appears designed to steer viewers toward injectable or IV products. The anti-aging framing is speculative in humans. The safety picture is incomplete. The creator has nursing credentials, which adds credibility to tone, but credentials don't make marketing claims into clinical evidence. Approach with skepticism.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
NAD+ Peptide Complex access requires the right clinical path
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 7 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For NAD+ injections: real metabolic tool or overhyped wellness shot?, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
NAD+ metabolism and its roles in cellular processes during ageing
Core review for NAD+ decline, mitochondrial function, DNA repair, and aging biology.
PubMed
Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women
Human NMN source for metabolic claims while keeping population limits clear.
PubMed
Emerging pharmacotherapies for obesity: A systematic review
Broad context for new and established obesity-drug categories.
PubMed
Glucagon-like receptor agonists and next-generation incretin-based medications
Current review for incretin-based obesity medications and cardiometabolic effects.
PubMed
Video claim decision path
Turn the claim into a safer next question
Direct answer
NAD+ Peptide Complex should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.
Evidence check
Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.
Safety check
A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.
Next step
Use the health tools and supporting evidence to prepare questions for your clinician.
Claim path
Keep researching this nad+ video claims cluster
Best for searchers separating NAD+ longevity marketing from practical metabolic and safety questions.
Claim verdict
The useful answer behind this video
Claim being checked
NAD+ is a coenzyme involved in mitochondrial electron transport and ATP synthesis, and plasma NAD+ levels do decline with age.
FormBlends verdict
NAD+ is a coenzyme involved in mitochondrial electron transport and ATP synthesis, and plasma NAD+ levels do decline with age. The creator promotes IV NAD+ as superior to oral supplementation, but peer-reviewed evidence from 2020 to 2023 shows that oral NAD+ precursors such as NMN and NR raise intracellular NAD+ levels in human subjects, making the oral absorption claim more nuanced than presented. IV NAD+ infusions carry documented side effects during administration and lack robust human RCT data supporting the cognitive, athletic, and anti-aging outcomes the video lists.
Patient-safe next step
Compare the claim with the NAD+ Peptide Complex guide, safety notes, access rules, and a licensed-provider review.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- NAD+ is a coenzyme involved in mitochondrial electron transport and ATP synthesis, and plasma NAD+ levels do decline with age. The creator promotes IV NAD+ as superior to oral supplementation, but peer-reviewed evidence from 2020 to 2023 shows that oral NAD+ precursors such as NMN and NR raise intracellular NAD+ levels in human subjects, making the oral absorption claim more nuanced than presented. IV NAD+ infusions carry documented side effects during administration and lack robust human RCT data supporting the cognitive, athletic, and anti-aging outcomes the video lists.
- NAD+ does function as a coenzyme in mitochondrial ATP production, confirmed in Rajman et al. (2018, Cell Metabolism), so the basic biochemistry the creator describes is not wrong.
- Oral NAD+ precursors NMN and NR raise intracellular NAD+ levels in humans, per Pencina et al. (2023, NEJM) and Martens et al. (2020, Nature Communications), undermining the video's claim that pills do nothing.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- NAD+ Peptide Complex decisions still need source quality, legal access, and provider oversight checks.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against the NAD+ Peptide Complex guide, cost path, safety notes, and provider review before acting.
Review NAD+ Peptide ComplexWhat You'll Learn
- NAD+ does function as a coenzyme in mitochondrial ATP production, confirmed in Rajman et al. (2018, Cell Metabolism), so the basic biochemistry the creator describes is not wrong.
- Oral NAD+ precursors NMN and NR raise intracellular NAD+ levels in humans, per Pencina et al. (2023, NEJM) and Martens et al. (2020, Nature Communications), undermining the video's claim that pills do nothing.
- No large-scale human RCTs have confirmed that IV NAD+ infusions outperform oral precursor supplementation for energy, cognition, or athletic performance in healthy adults.
- IV NAD+ infusions are associated with documented side effects during administration including nausea, flushing, and chest tightness, none of which were mentioned in this video.
- Anti-aging claims around NAD+ are based largely on animal models and observational aging data; human trial evidence for longevity outcomes remains limited and inconclusive as of 2024.
- NAD+ IV therapy is not FDA-approved for any of the conditions listed in the video, and these infusions are typically offered as wellness services outside the scope of approved indications.
- If you are considering NAD+ therapy in any form, consult a licensed provider who will review your baseline labs and medical history rather than recommending a protocol based on a social media video.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Courtney 🫶🏼 · TikTok creator
13.8K views on this video
Have you tried this!? #nadinjections #nadshot #ivinfusion #ivnurse #nursepractitionersoftiktok
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Courtney 🫶🏼, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.